Urinary drug metabolite testing in chronic heart failure patients indicates high levels of adherence with life‐prolonging therapies

Abstract Aims Despite medical therapy for heart failure (HF) having proven benefits of improving quality of life and survival, many patients remain under‐treated. This may be due to a combination of under‐prescription by medical professionals and poor adherence from patients. In HF, as with many oth...

Täydet tiedot

Bibliografiset tiedot

Päätekijät:	Mark Sweeney, Graham D. Cole, Punam Pabari, Savvas Hadjiphilippou, Upasana Tayal, Jamil Mayet, Neil Chapman, Carla M. Plymen
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	Oxford University Press 2021-06-01
Sarja:	ESC Heart Failure
Aiheet:	Heart failure ACE inhibitor Beta‐blocker Aldosterone antagonist Adherence Urinary testing
Linkit:	https://doi.org/10.1002/ehf2.13284
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!